Paragon Capital Management (Kansas)’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-160	Closed	-$13K	–	273
2019 Q1	$13K	Buy	+160	New	+$13K	0.01%	150